Profil
Peter Ordentlich is the founder of Syndax Pharmaceuticals, Inc. since 2005, serving as Chief Scientific Officer.
Former positions include Principal at The Salk Institute for Biological Studies and Research Scientist at X-Ceptor Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Aktive Positionen von Peter Ordentlich
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Gründer | 11.10.2005 |
Ehemalige bekannte Positionen von Peter Ordentlich
| Unternehmen | Position | Ende |
|---|---|---|
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Peter Ordentlich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
















